Denali Therapeutics vs PhosPrint
Denali Therapeutics vs PhosPrint, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Denali Therapeutics is on 70/100 and PhosPrint on 53/100.
Where each one leads
Denali Therapeutics
- our overall score: 70/100 against 53/100
- funding raised: $1.0B against $1.0M
PhosPrint
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Denali Therapeutics | PhosPrint |
|---|---|---|
| What it is | Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier. | Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications. |
| Category | Biotech, HealthTech, Drug Discovery, Neurotech | Biotech, MedTech, HealthTech, 3D Printing |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2015 | 2018 |
| Headquarters | South San Francisco, United States | Athens, Greece |
| Status | Active | Active |
Size, funding and growth
| Measure | Denali Therapeutics | PhosPrint |
|---|---|---|
| Employees | Not published | 10 |
| Total funding | $1.0B | $1.0M |
| Latest round | Royalty Funding | Seed |
| LinkedIn followers | Not published | 1,569 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Denali Therapeutics | PhosPrint |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 70/100 | 53/100 |
| Traction | Not published | 40/100 |
| Team | 36/100 | 70/100 |
| Search visibility | Not published | 36/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 57/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Denali Therapeutics | PhosPrint |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Wix |
| Frameworks | Tailwind CSS | Not detected |
| Analytics | Segment | Not detected |
Denali Therapeutics vs PhosPrint: common questions
Which is better, Denali Therapeutics or PhosPrint?
On our 0-100 score Denali Therapeutics rates higher (70/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Denali Therapeutics and PhosPrint compare on the numbers?
Denali Therapeutics leads on our overall score (70/100 against 53/100), funding raised ($1.0B against $1.0M).
Read the full Denali Therapeutics review and pricing or the PhosPrint review and pricing. You can also browse other Denali Therapeutics alternatives we track.